PPG vs. ICG in Gastrointestinal Resections
Launched by SAINT PETERSBURG STATE UNIVERSITY, RUSSIA · Jan 13, 2024
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different imaging methods to assess gastrointestinal anastomoses, which are the connections made between two parts of the digestive system after surgery. The researchers want to compare a new technique called Photoplethysmography (PPG) with the standard method known as Indocyanine Green (ICG) imaging to see which one works better at ensuring that these connections are healthy and well-perfused, meaning they have a good blood supply.
To participate in this study, individuals aged 65 and older who are undergoing gastrointestinal surgery and will have an anastomosis may be eligible. However, those who cannot give consent or have an allergy to the dye used in ICG imaging will not be able to take part. If you join the trial, you will undergo both imaging tests during your surgery, and the results will help improve future treatments for patients undergoing similar procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all gastrointestinal anastomoses
- Exclusion Criteria:
- • inability to consent
- • allergy against indocyaningreen dye
About Saint Petersburg State University, Russia
Saint Petersburg State University, established in 1724, is a prestigious institution in Russia known for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes through rigorous scientific investigation. With a focus on multidisciplinary collaboration, the university fosters partnerships with healthcare professionals, researchers, and industry stakeholders to conduct high-quality clinical trials that adhere to international standards. Its mission is to contribute to the global healthcare landscape by generating reliable data that informs clinical practices and therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yantai, Shandong, China
Saint Petersburg, Leningrad Oblast, Russian Federation
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported